SBDMRS
COTM
TYAKPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Seres Therapeuticsserestherapeutics.com TYDMRS |
Seres Therapeutics is a commercial-stage biotechnology company developing novel microbiome therapeutics for serious diseases, with | Cambridge, Massachusetts | 51-200 | — |
Artus Therapeuticsartustx.com  SJ |
Artus Therapeutics is a pre-clinical stage biotech company developing first-in-class oral small molecule therapeutics for inflamma | Boston, Massachusetts | 1-10 | — |
Adiso Therapeuticsadisotx.com SF  AP MM |
Adiso Therapeutics is a biotechnology company advancing a pipeline of multi-modal agents with novel mechanisms of action to treat | Newton Centre, Massachusetts | 11-50 | — |
Kaleidokaleido.com  EW NI |
Kaleido is a biotechnology research company founded in 2015 and based in Lexington, Massachusetts, that pursues life-changing ther | Lexington, Massachusetts | 1-10 | — |
Appliedmtappliedmt.com |
Applied Molecular Transport is a biotechnology company developing novel, oral biological therapeutics to treat severe autoimmune, | South San Francisco, California | 51-200 | — |
Achieving Cures Togetherachievingcures.com  MSCL |
Achieving Cures Together (ACT) is a 501(c)(3) non-profit based in St. Louis Park, Minnesota, that funds microbiome research at the | St. Louis Park, Minnesota | 1-10 | — |
Finch Therapeuticsfinchtherapeutics.com  HF WK PP |
Finch Therapeutics is a microbiome therapeutics company with a portfolio of investigational microbiome assets, including CP101 — a | Somerville, Massachusetts | 11-50 | — |
Axial Biotherapeuticsaxialbiotherapeutics.com |
Axial Therapeutics is a clinical-stage biopharmaceutical company developing gut-restricted, small molecule therapeutics for centra | Woburn, Massachusetts | 51-200 | — |
| Run live for more | ||||
Seres Therapeutics is a commercial-stage biotechnology company developing novel microbiome therapeutics for serious diseases, with its lead program VOWST™ FDA-approved in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI, commercialized in collaboration with Nestlé Health Science.
Companies like Seres Therapeutics include Artus Therapeutics, Adiso Therapeutics, Kaleido, Appliedmt, Achieving Cures Together. See the full list of 24 competitors and alternatives above.
Seres Therapeutics has approximately 51-200 employees and is in the Biotechnology Research industry.
Seres Therapeutics is headquartered in Cambridge, Massachusetts.
Seres Therapeutics operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Seres Therapeutics are listed above, including leaders across executive, finance, sales and operations.